Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain
CompletedNot applicableNCT01020162
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Neuralgic pain caused by entrapment of peripheral nerves is an often overlooked cause of chronic pelvic pain. The objective of the present study was to assess pain and quality of life in women with pain caused by entrapment of the ilioinguinal nerve, iatrogenic after surgery but also found without previous surgery. In a controlled prospective cross-over study 19 women were randomized either to medical treatment or to resection of the nerve. Statistically significant improvements were found after surgical resection.
Study details
- Official title
- Treatment of Ilioinguinal Entrapment Syndrome - a Randomised Controlled Trial
- Conditions
- Interventions
- Drug: Amitryptiline, gabapentin
- Procedure: Resection of the ilioinguinal nerve
- Sponsor
- Göteborg University
- Start date
- 1995-09
- Primary completion
- 2006-12
- Sex
- Female
- Age range
- from 15 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Sweden
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Pelvic pain in which a careful investigation has shown signs of ilioinguinal nerve entrapment Exclusion Criteria: * Drug abuse
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01020162